Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX1 | P07099 | 1/20 | 0.61 |
| ▸ | NAAA | Q02083 | 1/20 | 0.59 |
| ▸ | ACHE | P22303 | 6/20 | 0.53 |
| ▸ | TSHR | P16473 | 3/20 | 0.53 |
| ▸ | FAAH | O00519 | 1/20 | 0.53 |
| ▸ | ZDHHC7 | Q9NXF8 | 1/20 | 0.52 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.50 |
| ▸ | RAD52 | P43351 | 1/20 | 0.50 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.48 |
| ▸ | LMNA | P02545 | 1/20 | 0.48 |
| ▸ | DGKA | P23743 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1840884 | 1.00 | EPHX1 (0.61) | EPHX1NAAAACHETSHRFAAH | |
| SCHEMBL1837803 | 1.00 | EPHX1 (0.61) | EPHX1NAAAACHETSHRFAAH | |
| SCHEMBL1840170 | 1.00 | EPHX1 (0.61) | EPHX1NAAAACHETSHRFAAH | |
| SCHEMBL1833843 | 1.00 | EPHX1 (0.61) | EPHX1NAAAACHETSHRFAAH | |
| SCHEMBL1833746 | 1.00 | EPHX1 (0.61) | EPHX1NAAAACHETSHRFAAH | |
| SCHEMBL1839720 | 1.00 | EPHX1 (0.61) | EPHX1NAAAACHETSHRFAAH | |
| SCHEMBL1837221 | 1.00 | EPHX1 (0.61) | EPHX1NAAAACHETSHRFAAH | |
| SCHEMBL1835070 | 1.00 | EPHX1 (0.61) | EPHX1NAAAACHETSHRFAAH | |
| SCHEMBL1835358 | 1.00 | EPHX1 (0.61) | EPHX1NAAAACHETSHRFAAH | |
| SCHEMBL448774 | 1.00 | EPHX1 (0.61) | EPHX1NAAAACHETSHRFAAH |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 63 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3965765-A1 | OPIOID RECEPTOR ANTAGONIST PRODRUGS | Nirsum Laboratories, Inc. (US) | 2022-03-16 | — | — | EP | claimed |
| US-10308587-B2 | Functionalized fluoropolymers and electrolyte compositions | Blue Current, Inc. (US) | 2019-06-04 | — | — | US | claimed |
| US-10077231-B2 | Functionalized fluoropolymers and electrolyte compositions | Blue Current, Inc. (US) | 2018-09-18 | — | — | US | claimed |
| US-9543619-B2 | Functionalized phosphorus containing fluoropolymers and electrolyte compositions | Blue Current, Inc. (US) | 2017-01-10 | — | — | US | claimed |
| US-20160301107-A1 | FUNCTIONALIZED PERFLUOROALKANES AND ELECTROLYTE COMPOSITIONS | Blue Current, Inc. | 2016-10-13 | — | — | US | claimed |
| WO-2016126737-A1 | FUNCTIONALIZED FLUOROPOLYMERS AND ELECTROLYTE COMPOSITIONS | Blue Current, Inc. (US) | 2016-08-11 | — | — | WO | claimed |
| WO-2016126716-A1 | FUNCTIONALIZED PHOSPHORUS CONTAINING FLUOROPOLYMERS AND ELECTROLYTE COMPOSITIONS | Blue Current, Inc. (US) | 2016-08-11 | — | — | WO | claimed |
| US-20160226103-A1 | FUNCTIONALIZED FLUOROPOLYMERS AND ELECTROLYTE COMPOSITIONS | Blue Current, Inc. | 2016-08-04 | — | — | US | claimed |
| US-20160226104-A1 | FUNCTIONALIZED PHOSPHORUS CONTAINING FLUOROPOLYMERS AND ELECTROLYTE COMPOSITIONS | Blue Current, Inc. | 2016-08-04 | — | — | US | claimed |
| US-20160226102-A1 | FUNCTIONALIZED FLUOROPOLYMERS AND ELECTROLYTE COMPOSITIONS | Blue Current, Inc. | 2016-08-04 | — | — | US | claimed |
| CN-122055369-A | Bridged tricyclic carbamoyl pyridone compounds and uses thereof | 吉利德科学公司 | 2026-05-15 | — | — | CN | disclosed |
| US-12318403-B2 | 2′3′-cyclic dinucleotides and prodrugs thereof | INSTITUTE OF ORGANIC CHEMISTRY AND BIOCHEMISTRY ASCR, V.V.I. (CZ) | 2025-06-03 | — | — | US | disclosed |
| CN-114126615-B | Opioid receptor antagonist prodrugs | 尼萨姆实验室公司 | 2024-12-31 | — | — | CN | disclosed |
| EP-4446310-A1 | METHOD FOR PRODUCING BLOCKED ISOCYANATE COMPOUND AND METHOD FOR PRODUCING ISOCYANATE COMPOUND | Asahi Kasei Kabushiki Kaisha (JP) | 2024-10-16 | — | — | EP | disclosed |
| CN-118382612-A | Method for producing blocked isocyanate compound and method for producing isocyanate compound | 旭化成株式会社 | 2024-07-23 | — | — | CN | disclosed |
| US-7157442-B2 | Antibacterial compound | SANKYO COMPANY, LIMITED (JP) | 2007-01-02 | — | — | US | disclosed |
| CN-1699328-A | Process for preparing dialkyl carbonate | UNIV EAST CHINA SCIENCE & TECH (CN) | 2005-11-23 | — | — | CN | disclosed |
| EP-1209166-B1 | NOVEL A-500359 DERIVATIVES | SANKYO CO (JP) | 2004-03-31 | — | — | EP | disclosed |
| US-20030171330-A1 | Antibacterial compound | SANKYO COMPANY, LIMITED (JP) | 2003-09-11 | — | — | US | disclosed |
| EP-1209166-A1 | NOVEL A-500359 DERIVATIVES | Sankyo Company, Limited (JP) | 2002-05-29 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10308587-B2 | Functionalized fluoropolymers and electrolyte compositions | PEF1, PFAS, PFKFB3 | EPHX1 1076/4885NAAA 1146/4885ACHE 4089/4885 |
| US-20030171330-A1 | Antibacterial compound | TLR1, MPO, O60361 | EPHX1 3783/4885NAAA 1397/4885ACHE 3538/4885 |
| US-12318403-B2 | 2′3′-cyclic dinucleotides and prodrugs thereof | STING1, CGAS, NT5C2 | EPHX1 1704/4885NAAA 1097/4885ACHE 2455/4885 |
| US-10077231-B2 | Functionalized fluoropolymers and electrolyte compositions | PEF1, PFAS, PFKFB3 | EPHX1 1076/4885NAAA 1146/4885ACHE 4089/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.